Articles dans des revues avec comité de lecture (154)
  1. 23. Vachiery, J.-L., Galie, N., Barbera, J. A., Frost, A., Ghofrani, H. A., Hoeper, M. M., McLaughlin, V., Peacock, A., Simonneau, G., Blair, C., Miller, K. K., Langley, J., & Rubin, L. (2019). Initial combination therapy with ambrisentan + tadalafil on pulmonary arterial hypertension‒related hospitalization in the AMBITION trial. The Journal of heart and lung transplantation, 38(2), 194-202. doi:10.1016/j.healun.2018.11.006
  2. 24. Guiot, J., Parzibut, G., Weber, T., Davin, L., Dulgheru, R. E. R., Lancellotti, P., Louis, R., & Vachiery, J.-L. (2019). L'hypertension artérielle pulmonaire. RMLG. Revue médicale de Liège, 74(3), 139-145.
  3. 25. Frost, A., Hoeper, M. M., Barberà, J. A., Vachiery, J.-L., Blair, C., Langley, J., & Rubin, L. (2018). Risk-stratified outcomes with initial combination therapy in pulmonary arterial hypertension: Application of the REVEAL risk score. The Journal of heart and lung transplantation, 37(12), 1410-1417. doi:10.1016/j.healun.2018.07.001
  4. 26. Gall, H., Vachiery, J.-L., Tanabe, N., Halank, M., Orozco-Levi, M., Mielniczuk, L., Chang, M., Vogtländer, K., & Grünig, E. (2018). Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH. Lung, 196(3), 305-312. doi:10.1007/s00408-018-0112-z
  5. 27. Caravita, S., Dewachter, C., Soranna, D., D'Araujo, S. C., Khaldi, A., Zambon, A., Parati, G., Bondue, A., & Vachiery, J.-L. (2018). Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis. The European respiratory journal, 51(4). doi:10.1183/13993003.02427-2017
  6. 28. Vachiery, J.-L., Delcroix, M., Al Hiti, H., Efficace, M., Hutyra, M., Lack, G., Papadakis, K., & Rubin, L. (2018). Macitentan in pulmonary hypertension due to left ventricular dysfunction. The European respiratory journal, 51(2). doi:10.1183/13993003.01886-2017
  7. 29. Caravita, S., Faini, A., Carolino D'Araujo, S., Dewachter, C., Chomette, L., Bondue, A., Naeije, R., Parati, G., & Vachiery, J.-L. (2018). Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component. PloS one, 13(6), e0199164. doi:10.1371/journal.pone.0199164
  8. 30. McLaughlin, V., Pulido, T., Pepke-Zaba, J., Barberà, J. A., Hoeper, M. M., Vachiery, J.-L., Lang, I., Carvalho, F., Meier, C., Mueller, K., Nikkho, S., Jansa, P., D'Armini, A. M. A. A., Nielsen-Kudsk, J. E., Halank, M., Simonneau, G., Grünig, E., Ulrich, S., Rosenkranz, S., & Gomez Sanchez, M. A. (2017). Riociguat in patients with chronic thromboembolic pulmonary hypertension: Results from an early access study. BMC pulmonary medicine, 17(1), 216. doi:10.1186/s12890-017-0563-7
  9. 31. Royer, P. J., Antoine, M., Cappello, M., Souilamas, R., Ruiz, M., Sokolow, Y., Vanden Eynden, F., Van Nooten, G., Barvais, L., Berré, J., Brimioulle, S., De Backer, D., Creteur, J., Engelman, E., Huybrechts, I., Ickx, B., Preiser, T., Tuna, T., Van Obbergh, L., Vancutsem, N., Vincent, J. L., De Vuyst, P., Etienne, I., Féry, F., Jacobs, F., Knoop, C., Vachiery, J.-L., Van den Borne, P., Wellemans, I., Amand, G., Collignon, L., Giroux, M., et al. (2017). TLR3 promotes MMP-9 production in primary human airway epithelial cells through Wnt/β-catenin signaling. Respiratory research, 18(1), 208. doi:10.1186/s12931-017-0690-y
  10. 32. Hoeper, M. M., Dorfmuller, P., Guazzi, M., Galie, N., Manes, A., Handoko, M. L., Vonk-Noordegraaf, A., Lankeit, M., Konstantinides, S., Wachter, R., Opitz, C., Lam, C. C., Rosenkranz, S., Vachiery, J.-L., Bauersachs, J., Gerges, C., Lang, I., Bonderman, D., Olsson, K. K., & Gibbs, J. S. R. J. (2017). Pulmonary hypertension in heart failure with preserved ejection fraction: A plea for proper phenotyping and further research. European heart journal, 38(38), 2869-2873. doi:10.1093/eurheartj/ehw597
  11. 33. Naeije, R., Gerges, M., Vachiery, J.-L., Caravita, S., Gerges, C., & Lang, I. (2017). Hemodynamic phenotyping of pulmonary hypertension in left heart failure. Circulation. Heart Failure, 10(9), e004082. doi:10.1161/CIRCHEARTFAILURE.117.004082
  12. 34. Coghlan, J. G., Simonneau, G., Vachiery, J.-L., Blair, C., Gillies, H., Miller, K. K., Harris, J. H. N., Langley, J., Rubin, L., Galie, N., Barberà, J. A., Frost, A., Ghofrani, H. A., Hoeper, M. M., Kuwana, M., McLaughlin, V., & Peacock, A. J. (2017). Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): Subgroup analysis from the AMBITION trial. Annals of the Rheumatic Diseases, 76(7), 1219-1227. doi:10.1136/annrheumdis-2016-210236
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Suivant >>